{"name":"FAScinate Therapeutics Inc.","slug":"fascinate-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxORGxFSnFkVFVFSzlUN3MtaVdwWUxMcldycVItejFGWHg3d2NDSXFheEFBUEtINXZNNjVjX3pUbkNCWWpxWXJQb28xVHFJNUNES1NBUHp4cFBFb1NrQzliT3FtallRaHIxRDh6YXl4U3hhandRZlhoVmxMekFVMF9pUG1FQWY0cTQ3WlU0UTgtREdTTWd2THBTSkZsZEJXOWwyODVEQmduSVNLd2U5N0pMNjZHeUZtcmprdThvdnFPMGM2aW5YdlhwUWtWM050RnVDLUxxVjNpeWpzQ0lDOWozX1VZOVVFTzMtM19UMWtBc2JVNHFIS2tYMnVpeDBDZjRQdzl2eUhZcnc1alBfSzJCNGk0Q3k5dEZGX0g0Z1NiOW04NWVzOVMtbFhWcFliWWhtMkIzQjQySmcwaV93dXJPY1F5c2xrdk1WUzZ6Q210Wktxdw?oc=5","date":"2026-04-03","type":"pipeline","source":"Barchart.com","summary":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro -","headline":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPZG1pZlNEOUpKZVo1UC1seGhDWWNqMnpfSHloZlJYSW03VE1XZTcwb2xIVGgtNXI5dnFkUUdnSDJXdVlMTU4zYkUxMjh3ZDk0OE95c184cXFGNEgzUlN5R21ldlFTM1YyX3ZoNk5TS1hnWlNibE1zTmpmdzFULTRQTVZINEZ1aDh5RGxsS0hLQlVsall3LXZkYU0xdERaU3pZYWk1SlU1ZGU4Q2F6STd6aDBLQS1XUkpMZWVlVEQwOGwyakhteFdrTDZ3S3h2WFZIVnY2a3B4X0JtOENlX21TWmxmLWtkX1V6VGp2cERzN29NMkxZdjQ0U2p0cXhyNkJrTnJrRG10ems4VzVITnpzY2V2SGMtRXNobk9KQXc1R29Hc181SlJTN21wOVZkWEVXaFJaOWd1WVQ2VkJuQUZrdkZOdjhCdDg?oc=5","date":"2025-08-20","type":"regulatory","source":"Barchart.com","summary":"Parkinson’s Disease Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail - Barc","headline":"Parkinson’s Disease Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbnpLNGxqM1dUX3VWbkJEaWZ1dzY2SWhEUEY3am5VSkNGS1U1czl6S1JKbklnOW9CbzdOZzloQnZLSTFBMnY1TzVIN1AtNFJ3SmhXSUcxRFowTXRDenpkZFlKRmt2cEhRc2QzcFRPMU54dG40bmZoWVF4SUVrNlNhWHNpVnA0LVRrak84MjBpUmRCUk0?oc=5","date":"2025-03-20","type":"regulatory","source":"openPR.com","summary":"Parkinson's Disease Pipeline 2025: FDA Updates, Therapy - openPR.com","headline":"Parkinson's Disease Pipeline 2025: FDA Updates, Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQNVhrTXZZaGxYVFp0ZzZDM3lFTGxXdjdpTlJfcm1CbmV4WEY0N1V0djRaMzN6d3UxLUNsUDBqdHFRTXRVeTdqTFVaVnF5cGJKZE52M0tIQ1ljVVBNVUNjV1FXWnR5X2lSaTUySFRvWXZ6Q1BmNUI0ME9mVFJHT0NVNnM1eGtLTVRRSjNZ?oc=5","date":"2024-10-10","type":"trial","source":"The Lancet","summary":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial - The Lancet","headline":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomis","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}